The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A study on oligo-progression after durvalumab plus platinum-etoposide for ES-SCLC.

Kageaki  Watanabe

Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Merck; MSD; Ono Pharmaceutical; Takeda

Kazuhito  Misawa

No Relationships to Disclose

Mao  Uematsu

No Relationships to Disclose

Kana  Hashimoto

No Relationships to Disclose

Yukio  Hosomi

Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Kirin International; Lilly Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical